LMNA-Cardiomyopathy in Emery-Dreifuss Muscular Dystrophy

Emery-Dreifuss muscular dystrophy is a rare disease resulting from a genetic defect in nuclear envelope proteins, most commonly in emerin and lamin A/C. The disease is characterized by slowly progressing weakness of the scapular-brachial and pelvic-peroneal muscle groups, myodystrophy, primary joint...

Full description

Saved in:
Bibliographic Details
Main Authors: E. V. Resnik, A. A. Kovaleva, M. Kh. Shurdumova, D. E. Emelyanovich, A. P. Smirnov, V. Y. Voinova
Format: Article
Language:Russian
Published: SINAPS LLC 2024-10-01
Series:Архивъ внутренней медицины
Subjects:
Online Access:https://www.medarhive.ru/jour/article/view/1854
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849303188379795456
author E. V. Resnik
A. A. Kovaleva
M. Kh. Shurdumova
D. E. Emelyanovich
A. P. Smirnov
V. Y. Voinova
author_facet E. V. Resnik
A. A. Kovaleva
M. Kh. Shurdumova
D. E. Emelyanovich
A. P. Smirnov
V. Y. Voinova
author_sort E. V. Resnik
collection DOAJ
description Emery-Dreifuss muscular dystrophy is a rare disease resulting from a genetic defect in nuclear envelope proteins, most commonly in emerin and lamin A/C. The disease is characterized by slowly progressing weakness of the scapular-brachial and pelvic-peroneal muscle groups, myodystrophy, primary joint contracture and cardiomyopathy with rhythm disorders and conduction abnormalities. Cardiovascular complications and life-threatening arrhythmias are the main cause of death in such patients at a young age. Depending on the leading symptoms and family history, patients are under the care of different specialists. Unfortunately, neurologists, cardiologists, cardio surgeons and orthopedics are not well informed about this rare condition and thus the disease tends to be not diagnosed in time. This article examines the data of epidemiology, pathophysiology, features of the course, diagnosis, approaches to the management of cardiovascular pathology in progressive Emery-Dreyfus muscular dystrophy with the development of LMNA cardiomyopathy. A clinical case of this disease is also given.
format Article
id doaj-art-af07933353124e52bb3a34efdb82b2e1
institution Kabale University
issn 2226-6704
2411-6564
language Russian
publishDate 2024-10-01
publisher SINAPS LLC
record_format Article
series Архивъ внутренней медицины
spelling doaj-art-af07933353124e52bb3a34efdb82b2e12025-08-20T04:00:03ZrusSINAPS LLCАрхивъ внутренней медицины2226-67042411-65642024-10-0114538139310.20514/2226-6704-2024-14-5-381-3931013LMNA-Cardiomyopathy in Emery-Dreifuss Muscular DystrophyE. V. Resnik0A. A. Kovaleva1M. Kh. Shurdumova2D. E. Emelyanovich3A. P. Smirnov4V. Y. Voinova5Pirogov Russian National Research Medical University; City Clinical Hospital № 31 named after academician G M Savelyeva of the Department of Health of the City of MoscowPirogov Russian National Research Medical University; City Clinical Hospital № 31 named after academician G M Savelyeva of the Department of Health of the City of MoscowPirogov Russian National Research Medical University; City Clinical Hospital № 31 named after academician G M Savelyeva of the Department of Health of the City of MoscowCity Clinical Hospital № 31 named after academician G M Savelyeva of the Department of Health of the City of MoscowPirogov Russian National Research Medical University; City Polyclinic № 212 of the Department of Health of the City of MoscowPirogov Russian National Research Medical UniversityEmery-Dreifuss muscular dystrophy is a rare disease resulting from a genetic defect in nuclear envelope proteins, most commonly in emerin and lamin A/C. The disease is characterized by slowly progressing weakness of the scapular-brachial and pelvic-peroneal muscle groups, myodystrophy, primary joint contracture and cardiomyopathy with rhythm disorders and conduction abnormalities. Cardiovascular complications and life-threatening arrhythmias are the main cause of death in such patients at a young age. Depending on the leading symptoms and family history, patients are under the care of different specialists. Unfortunately, neurologists, cardiologists, cardio surgeons and orthopedics are not well informed about this rare condition and thus the disease tends to be not diagnosed in time. This article examines the data of epidemiology, pathophysiology, features of the course, diagnosis, approaches to the management of cardiovascular pathology in progressive Emery-Dreyfus muscular dystrophy with the development of LMNA cardiomyopathy. A clinical case of this disease is also given.https://www.medarhive.ru/jour/article/view/1854emery-dreifusscardiomyopathylaminopathylmnamuscular dystrophy
spellingShingle E. V. Resnik
A. A. Kovaleva
M. Kh. Shurdumova
D. E. Emelyanovich
A. P. Smirnov
V. Y. Voinova
LMNA-Cardiomyopathy in Emery-Dreifuss Muscular Dystrophy
Архивъ внутренней медицины
emery-dreifuss
cardiomyopathy
laminopathy
lmna
muscular dystrophy
title LMNA-Cardiomyopathy in Emery-Dreifuss Muscular Dystrophy
title_full LMNA-Cardiomyopathy in Emery-Dreifuss Muscular Dystrophy
title_fullStr LMNA-Cardiomyopathy in Emery-Dreifuss Muscular Dystrophy
title_full_unstemmed LMNA-Cardiomyopathy in Emery-Dreifuss Muscular Dystrophy
title_short LMNA-Cardiomyopathy in Emery-Dreifuss Muscular Dystrophy
title_sort lmna cardiomyopathy in emery dreifuss muscular dystrophy
topic emery-dreifuss
cardiomyopathy
laminopathy
lmna
muscular dystrophy
url https://www.medarhive.ru/jour/article/view/1854
work_keys_str_mv AT evresnik lmnacardiomyopathyinemerydreifussmusculardystrophy
AT aakovaleva lmnacardiomyopathyinemerydreifussmusculardystrophy
AT mkhshurdumova lmnacardiomyopathyinemerydreifussmusculardystrophy
AT deemelyanovich lmnacardiomyopathyinemerydreifussmusculardystrophy
AT apsmirnov lmnacardiomyopathyinemerydreifussmusculardystrophy
AT vyvoinova lmnacardiomyopathyinemerydreifussmusculardystrophy